Equinox Receives $14 Million Investment

Equinox, Inc.

Represented Equinox, Inc. in connection with its agreement to receive $14 million of development capital from Equinox I, LLC, an investment firm managed by Flying L Partners, LLC.

Equinox is a medical device company that uses adjustable, non-surgical, non-pharmacologic technologies to treat diseases of the optic nerve such as glaucoma, by balancing intraocular pressure with intracranial pressure.

The Newport Beach-based deal team representing Equinox included Bruce Feuchter, Jeff Estes, Ryan GaglioArash Lessantiz and Jon Krane.